Skip to main content
Article
Comparison of P53 mutation status, primary cytoreductive surgical outcomes, and overall survival in patients with ovarian cancer
Proceedings in Obstetrics and Gynecology
  • David Engle, University of Iowa
  • Hubert Fornalik, University of Iowa
  • Traci Neff, University of Iowa
  • Anna Button, University of Iowa
  • K Collins, University of Iowa
  • Amina Ahmed, University of Iowa
  • David Bender, University of Iowa
  • Susan Lutgendorf, University of Iowa
  • Michael Goodheart
Peer Reviewed
0
Publication Date
7-28-2011
Abstract
Optimal surgical cytoreduction continues to be an important prognostic variable in patients with ovarian cancer independent of p53 mutational status. Among patients with suboptimal cytoreduction a p53 mutation may offer a survival advantage.
Keywords
  • P53,
  • cytoreductive surgery,
  • survival,
  • ovarian cancer
Total Pages
2
Rights
Copyright © David Engle, Hubert Fornalik, Traci Neff, Anna Button, K Collins, Amina Ahmed, David Bender, Susan Lutgendorf, Michael J. Goodheart, 2011
Creative Commons License
Creative Commons Attribution 3.0
Citation Information
David Engle, Hubert Fornalik, Traci Neff, Anna Button, et al.. "Comparison of P53 mutation status, primary cytoreductive surgical outcomes, and overall survival in patients with ovarian cancer" (2011) p. 1 - 2 ISSN: 2154-4751
Available at: http://works.bepress.com/david_bender/4/